- Home
- GRFS vs ESNT Comparison
GRFS vs ESNT Comparison
Compare GRFS & ESNT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GRFS | ESNT |
|---|---|---|
| Founded | 1940 | 2008 |
| Country | Spain | Bermuda |
| Employees | 25247 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.2B | 5.9B |
| IPO Year | N/A | 2013 |
Fundamental Metrics
Financial Performance| Metric | GRFS | ESNT |
|---|---|---|
| Price | $7.87 | $66.16 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | $10.15 | ★ $67.29 |
| AVG Volume (30 Days) | ★ 720.6K | 486.4K |
| Earning Date | 07-28-2022 | 05-08-2026 |
| Dividend Yield | 1.80% | ★ 2.19% |
| EPS Growth | N/A | ★ 0.73 |
| EPS | N/A | ★ 1.82 |
| Revenue | N/A | ★ $1,260,935,000.00 |
| Revenue This Year | $4.49 | $1.12 |
| Revenue Next Year | $6.42 | $3.37 |
| P/E Ratio | ★ $18.67 | $36.58 |
| Revenue Growth | N/A | ★ 1.45 |
| 52 Week Low | $6.96 | $55.34 |
| 52 Week High | $10.88 | $68.62 |
Technical Indicators
Market Signals| Indicator | GRFS | ESNT |
|---|---|---|
| Relative Strength Index (RSI) | 53.79 | 56.08 |
| Support Level | $7.45 | $59.24 |
| Resistance Level | $8.35 | $66.97 |
| Average True Range (ATR) | 0.19 | 1.40 |
| MACD | 0.07 | -0.07 |
| Stochastic Oscillator | 55.47 | 53.48 |
Price Performance
Historical ComparisonAbout GRFS Grifols S.A.
Grifols SA is a healthcare company engaged in activities related to plasma-derived products and diagnostic solutions. The group has four reportable segments: Biopharma, Diagnostic, Bio Supplies, and Others. The Biopharma segment focuses on products derived from human plasma for therapeutic use, while the Diagnostic segment includes the marketing of diagnostic testing equipment and reagents. The Bio Supplies segment covers biological products for non-therapeutic use and plasma sales to third parties, and the Others segment includes manufacturing services, research activities, and complementary pharmaceutical products.
About ESNT Essent Group Ltd.
Essent Group Ltd serves the housing finance industry by providing private mortgage insurance, reinsurance, risk management products, title insurance, and settlement services to mortgage lenders, borrowers, and investors to support homeownership. It provides credit protection to lenders and mortgage investors by covering a portion of the unpaid principal balance of a mortgage and certain related expenses in the event of a default. By providing capital to mitigate mortgage credit risk, the company allows lenders to make additional mortgage financing available to prospective homeowners.